Paraganglioma
📧 Sign up to get email alerts when something new happens for Paraganglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma [NA]
A completed clinical trial from University Hospital, Rouen evaluated the specificity of elevated plasma EM66 levels for pheochromocytoma and…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]
Clinical trial update for EO2401 in metastatic adrenocortical carcinoma and malignant pheochromocytoma/paraganglioma reports termination of …
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma [NA]
A clinical trial is evaluating the PET/CT tracer Al18F-NOTA-LM3 in patients with pheochromocytoma and paraganglioma, and the study is curren…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating cabozantinib S-malate in patients with metastatic or unresectable pheochromocytoma or paraganglioma; results were p…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs [Phase 2]
Phase 2 study evaluating safety and dosimetry of Lutathera (lutetium-177 DOTATATE) in adolescent patients with gastroenteropancreatic neuroe…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics
This clinical trial update analyzes the relationship between preoperative imaging of pheochromocytoma and paraganglioma (PPGL) and intraoper…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma [Phase 2]
Phase 2 trial evaluating Sunitinib in patients with recurrent paraganglioma and pheochromocytoma; the study is completed and results have be…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: "Receptor Radionuclide Therapy With 177Lu-DOTATOC [Phase 2]
A Phase 2 trial evaluating receptor radionuclide therapy with 177Lu-DOTATOC for neuroendocrine tumors, including paraganglioma and pheochrom…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma [Phase 2]
Phase 2 trial update showing efficacy and safety data for anlotinib in patients with metastatic pheochromocytoma or paraganglioma.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) [NA]
The MICROBAT trial investigating infrared thermography for detection of brown adipose tissue was terminated, involving patients with pheochr…
-
CLINICAL_TRIALS trial_result · 2023-11-20Clinical Trial Update: Preoperative Alpha Blockade for Pheochromocytoma [Phase 3]
Phase 3 trial evaluating preoperative alpha blockade for pheochromocytoma and paraganglioma has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL [Phase 2]
Phase 2 study evaluating temozolomide as neoadjuvant therapy for pheochromocytoma and paraganglioma.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL [Phase 2]
Phase 2 trial update evaluating safety and effectiveness of anlotinib as neoadjuvant therapy for pheochromocytoma and paraganglioma.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: The Efficacy and Safety of Temozolomide in Patients With MPPGL [Phase 2]
Phase 2 trial evaluating temozolomide for malignant pheochromocytoma and paraganglioma has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma [Phase 2]
A Phase 2 randomized international trial in malignant progressive pheochromocytoma and paraganglioma has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial [Phase 2]
Phase II open-label single-arm study evaluating efficacy and safety of anlotinib in advanced or metastatic pheochromocytoma/paraganglioma.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating lenvatinib for metastatic or advanced pheochromocytoma or paraganglioma that cannot be surgically removed;…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer [Phase 2]
A Phase II trial of the DNA methyltransferase inhibitor guadecitabine (SGI-110) in children and adults with wild-type GIST, paraganglioma, p…
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma [Phase 2]
Phase II study evaluating axitinib (AG-013736) targeting VEGF pathway in metastatic/recurrent/unresectable pheochromocytoma and paragangliom…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Dovitinib in Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib in neuroendocrine tumors (paraganglioma and pheochromocytoma) completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: GA-68 DOTA-TOC of Somatostatin Positive Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for GA-68 DOTA-TOC targeting somatostatin receptors in neuroendocrine tumors and related malignancies, with …
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma [Phase 2]
Phase 2 study evaluating ultratrace Iobenguane I-131 in malignant relapsed/refractory pheochromocytoma and paraganglioma; results posted in …
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors [Phase 2]
Phase II clinical trial evaluating 131I-Metaiodobenzylguanidine (MIBG) for metastatic or unresectable pheochromocytoma and related tumors ha…